Corporate Partners

Thank you to our ISCT 2023 Corporate Partners

At Cytiva, we believe the key to transforming human health is accessing life-changing therapies. That's why our 10,000+ associates in more than 40 countries are keenly focused on helping researchers, biopharma companies, and drug manufacturers to advance and accelerate therapeutics for people that need them.

Learn more at

Visit Website
MaxCyte® is a leading provider of cell-engineering platform technologies and is responsible for helping to bring next‐generation cell-based therapies to life. The Company's technology is employed by leading drug developers worldwide, including 20 of the top 25 global biopharmaceutical companies. Our Flow Electroporation® technology and next-generation ExPERT™ platform enable our partners to accelerate, streamline, and improve the drug development process from the early stages of research to commercialization. Founded in 1998, MaxCyte is headquartered in Gaithersburg, Maryland, U.S.

Visit Website
Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy. Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing. Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training. Today, Miltenyi Biotec has more than 4,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Visit Website
Terumo Blood and Cell Technologies is a medical technology company. Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today.

Visit Website
A global leader in in-vitro diagnostics for over 55 years, bioMérieux has always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. The Company is present in 44 countries and serves more than 160 countries with the support of a large network of distributors. It provides diagnostic solutions that improve patient health and ensure consumer safety. At bioMérieux, we are proud to have a long history in the field of industrial microbiology. Cutting-edge cell and gene therapy products demand state-of-the-art quality control. With a comprehensive portfolio of rapid microbiology testing solutions, bioMérieux can help streamline workflows, boost efficiency, prevent compliance issues and ensure patient safety.

Visit Website
Roche CustomBiotech - We provide reliable, tailor-made and high-quality raw materials, kits and technologies to biopharma and diagnostics companies.

Roche CustomBiotech enables the healthcare industry in bringing state-of-the-art diagnostics and treatments to those in need. With the CustomBiotech division Roche merged its innovative technologies, excellent knowledge, and decades of experience in the Biopharma and Diagnostics Industry. The site in Penzberg, Germany, is Roche´s powerhouse of manufacturing and its excellence in manufacturing enables companies in Biopharma or Diagnostics to get access to tailored solutions meeting the highest standards in quality, safety and regulatory requirements, from ISO-certified quality management to GMP, animal-free and antibiotic-free production of excipients, raw materials, kits and innovative instruments. The products from Roche CustomBiotech are off the shelf or customizable to meet excellent quality and regulatory needs. Quality, Innovation and the individual customer interest are in the center of the Roche CustomBiotech´s business, pathing the way for an ever expanding product portfolio meeting the current interests and needs of our customers and thereby enabling innovative drugs and products.

Visit Website
ScaleReady is a joint venture between Bio-Techne, Fresenius Kabi, and Wilson Wolf. Bringing together proven tools and technologies for cell culture, cell activation, gene editing, and cell processing, ScaleReady provides leading therapeutic developers with the most simple, scalable, and versatile manufacturing platform in the industry. Our platform includes GRex® cell culture technology, the Lovo and Cue cell processing systems, and a wide range of GMP proteins, reagents, media, and gene editing technologies.

Visit Website
Driven by science and a passion for quality, STEMCELL Technologies offers over 2500 tools and services to support discoveries in fields such as regenerative medicine, immunotherapy, and disease research. Whether you're culturing and editing hematopoietic stem and progenitor cells, differentiating pluripotent stem cells, or activating and expanding immune cells, we have the specialized cell isolation products, high-performance cell culture media, and accessory tools for your research. By increasing the accessibility of innovative techniques like gene editing and organoid cultures, we’re helping scientists accelerate the pace of discovery—so they can get therapies to patients faster. Researchers in need of high-compliance products can also obtain guidance and customized support through our Services for Cell Therapy Program on how to qualify our products for use as raw/ancillary materials. To learn more, visit

Visit Website
As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support need to accelerate the pace of cell and gene therapy development. We understand the complexity of this rapidly-evolving industry and have made significant investments in cGMP raw material manufacturing and drug product manufacturing capabilities to provide innovative workflow solutions. Partner with us to access the high-quality materials, services, and support you need from discovery to clinical research and commercial cell and gene manufacturing. Through our Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab services, Patheon, and Gibco brands, we offer an unmatched combination of innovative technologies, manufacturing, and distribution capabilities.

Visit Website
Akron Bio drives advanced therapy development and commercialization with high-quality, industrial-scale solutions. Akron’s strategic focus is supplying cGMP-compliant ancillary materials and services to enable the advancement of cell and gene therapies. These include cytokines and growth factors, human sera and purified proteins, plasmid DNA manufacturing, and custom development services. Akron supports clients with rigorous documentation and quality standards to fulfill their regulatory demands. Our unique capabilities allow us to seamlessly transition from R&D to preclinical and clinical and drive the emerging regenerative medicine sector to unmet clinical needs through affordable and seamless manufacturing options.

Visit Website
BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services. Our portfolio includes our proprietary CryoStor® freeze media and HypoThermosol® shipping and storage media, ThawSTAR® family of automated, water-free thawing products, evo® cold chain management system, Custom Biogenic Systems® high-capacity cryogenic storage freezers, SciSafe biologic materials storage, Stirling Ultracold ULT freezers, and Sexton Biotechnologies cell processing tools. For more information, please visit,, and and follow BioLife on Twitter.

Visit Website
Cellares is creating the future of cell therapy manufacturing and accelerating access to life-saving cell therapies. The company is developing a one-of-a-kind solution to overcome the limitations associated with manufacturing cell therapies that are more affordable and widely available to patients in need. With Cellares’s proprietary platform—the Cell Shuttle—biopharma companies, academic research centers, and CDMOs will no longer have to compromise by either choosing a manufacturing platform that is semi-automated but lacks workflow flexibility, or one that provides customization but not the end-to-end automation needed to manufacture at scale. The company is headquartered in South San Francisco, CA.

Visit Website
FUJIFILM Irvine Scientific supports cell and gene therapy manufacturers with over 50 years of cell culture media knowledge and expertise. Our products advance the development of processes and workflows, to help users obtain optimal performance and safety of their final manufactured cells. We deliver high-performance media and expert support that can directly influence advanced cell and gene therapies. By providing innovative, first-to-market products and workflow solutions, we holistically drive and accelerate user efforts with complete media solutions for basic, translational, and clinical research, as well as commercial applications.

Visit Website
Mayo Clinic's Center for Regenerative Biotherapeutics seeks to integrate, develop and deploy new regenerative medicine products and services that continually differentiate Mayo's practice to draw patients from around the world for complex care.

Visit Website
WuXi Advanced Therapies is a global Contract Testing Development and Manufacturing Organisation (CTDMO) headquartered in Philadelphia, USA, in the heart of the cell and gene therapy industry. It is the advanced therapies business unit of WuXi AppTec and provides innovative technology platforms for lentiviral and AAV plasmid, viral vector and cell therapy manufacture and testing, accelerating time to market for cell and gene therapies.
We are a comprehensive provider of viral vector and cell therapy testing for the advanced therapy industry, conducting testing for both therapeutics developers and other CDMOs. With OXGENE as our UK-based discovery engine, our in-house testing capabilities and significant manufacturing expertise combine to provide a fully integrated end-to-end solution for cell and gene therapy research, development, testing and GMP manufacture that delivers a critical competitive advantage to our customers as we work together to cure faster and cure more.

Visit Website
Accellix aims to bring the power of flow cytometry to the GMP manufacturing floor, automating the entire GMP cell phenotyping process from sample preparation to data analysis with the Accellix platform. We bring automated sample preparation, flow cytometry and data analysis into the cell therapy GMP manufacturing suite.
Our team is an interdisciplinary group composed of skilled biologists, engineers, mathematicians, technicians and more with deep experience in all aspects of the immunotherapy field and platform. Accellix has growing offices in Jerusalem, Israel and San Jose, CA.

Visit Website
Aenitis develop and promote devices for continuous, contactless and pressureless cells handling, using acoustic forces. Aenitis focus on cell and gene therapy players' challenges by developing innovative cost-effective bioprocessing systems for cell sorting, cell washing, cell confinement and cell isolation.

Visit Website
AMSBIO is contributing to the acceleration of discovery through the provision of cutting-edge life science products and services for R&D. We are able to provide solutions for studying cell motility, migration, invasion and proliferation. We also offer solutions for organoid and spheroid culture, regenerative medicine and stem cell research.

Visit Website
Arvato offers a fully integrated order-2-cash business model for both, healthcare providers and manufactures of Cell & Gene therapies. We manage the complexity of our client’s supply chains on a global scale. Our clients benefit from seamlessly integrated order-2-cash solutions with a dedicated focus on Cell & Gene therapies:
• Orchestration Platform & Integrations
• Case Management & Customer Services
• Temperature Controlled Warehousing at 18 international sites
• Postponement Services
• Transport Management
• Financial Services
• GMP + GDP Certified

Arvato integrates healthcare know-how, industry knowledge and broad understanding of processes and IT systems to develop bespoke outsourcing solutions. We connect our clients to the point of care, bringing them closer to their patients.

Visit Website
ASEPTIC TECHNOLOGIES develops, manufactures and markets innovative aseptic solution for the BioPharmaceutical industry.

Its equipment and devices are designed to provide safer & easier operations for aseptic fill and finish, the best-known being the AT-Closed Vial® technology.

The AT-Closed Vial® is manufactured in ISO 5 clean room with the stopper secured in place and gamma sterilized. Vial size ranges from 1 to 50ml. The filling of these ready-to-use vials is performed by a special needle piercing the stopper and dispensing the drug product. The stopper is then immediately resealed by a laser and a cap is snap-fitted on it. Various equipment offer an easy scale-up from manual to fully automated operation.

The benefits of the technology are: better sterility assurance, reduced investments, increased safety during whole supply chain, strong operating cost reduction.

The AT-Closed Vial® technology is widely used in the Cell and Gene Therapies as it offers uncompromised container closure integrity even during storage at cryogenic temperature.

Visit Website
Azenta Life Sciences provides unrivaled sample exploration and management solutions to help our customers accelerate discovery, development, and delivery to bring impactful breakthroughs and therapies to market faster. We are the global leader in automated compound management for drug discovery, biological storage, and sample processing solutions. Azenta understands the importance of sample integrity and provides a comprehensive range of solutions across our leading capabilities of genomic services, sample repository services (SRS), consumables and instruments, data management and informatics, sample sourcing, and automated ultra-cold storage.

Visit Website
Barkey is a German family business for medical technology in the field of warming devices. Founded in 1980 by Volker Barkey, Thomas (CFO) and Christian Barkey (CEO) together with Armin Nowack (COO) and the entire staff have led the company to worldwide awareness in the hospital and blood bank sector as well as in cell & gene therapy research. Barkey’s two main goals: Preventing hypothermia and advancing Cell & Gene research to develop cancer therapies. Therefore, Barkey produces solutions for warming or thawing blood products, cellular materials, infusion solutions, etc. The safety of samples, user and, of course, patients is of priority. Barkey relies exclusively on dry heating systems since the use of open water baths offers a high risk of contamination. This must be avoided both, during the preparation of patient treatment and during the research and production of new therapeutic procedures. Barkey is part of the Azenta Group. The company is headquartered in Leopoldshoehe, NRW. Two subsidiaries in Boston, MA, US and Shanghai, CN as well as an extensive distributor network enable the worldwide availability of the TÜV and FDA certified products.

Visit Website
BioCanRx is Canada’s Immunotherapy Network. Our vision is to turn all cancers into curable diseases. We are a network of scientists, clinicians, cancer stakeholders, academic institutions, NGOs and industry partners working together to accelerate the development of leading-edge immune oncology therapies for the benefit of patients. As a leader in the translation, manufacture and adoption of cancer immunotherapies, we invest in translating world-class technologies from the research lab into clinical trials. BioCanRx provides researchers with access to funding, expertise, training and biomanufacturing facilities. We train and develop the talent needed for a thriving Canadian health biotechnology sector. BioCanRx receives funding from the federal government’s Networks of Centres of Excellence, and support from industry, the provinces and charities. The network is hosted by the Ottawa Hospital Research Institute.

Visit Website
Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. It was purchased by GC of South Korea for $73M in May 2022. With over 50 scientists, engineers, analysts, and manufacturing specialists, the company has established quality systems and the infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing and has expertise in a variety of cell and vector types. Their 25,000 square feet of facilities includes four ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. It is also home to the only McKinsey-owned Digital Capability Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences. For more information, visit

Visit Website
BioLamina AB is a Swedish biotechnology company built on a scientific foundation with a legacy in matrix biology and cell culture-based research. Our flagship products, our biorelevant human recombinant laminin isoforms, Biolaminin®, are defined cell culture matrices that successfully imitate the natural, cell-specific cell-matrix interaction in the cell culture dish, allowing the cells to thrive and maintain their function. Our products are a powerful resource for scientists working with stem cells and primary cells both within basic research as well as in regenerative medicine companies with a focus on cell therapy applications.

Visit Website
At BioLegend we know that to make a difference for all, we need to make a difference with our products. Our scientists are proud to create world-class, cutting-edge antibodies and reagents across a diverse set of research areas—from immunology and cancer research to neuroscience and stem cells. Founded by scientists for scientists, we aren’t just making a difference, we are different. We’re accelerating research and discovery by providing high-quality, purpose-driven products at an outstanding value. With over 28,000 trusted reagents, 80,000+ citations in peer-reviewed publications, and a dedicated team to create custom solutions for you, there’s nothing our expertise doesn’t cover. Discover the BioLegend difference to see how we can make an impact in your lab and beyond. Learn more at

Visit Website
For over 30 years, Bionique Testing Laboratories continues to be a trusted partner and global leader in Mycoplasma Testing Services for the life science industry. We offer the full range of testing services from relevant compendia (USP <63> Mycoplasma Test) to a GMP compliant Real-Time PCR assay to support the development and clinical manufacturing of cell & gene therapies. From discovery to commercialization, our capabilities extend to method development and validation of rapid microbial methods to meet global regulatory requirements. Bionique delivers testing services that meet the highest quality standards and offers the fastest turnaround times in the industry.

Visit Website
Bio-ReCell is a cell therapy research and development company that has developed the first closed and automated system for target cell separation and isolation that yields pure and viable cells. The Bio-ReCell System uses a proprietary antibody-based technology that does not use magnetic particles and produces cell eluates with no contaminants such as residual antibodies, chemicals, and particles. Cell isolation is performed in sterile, biocompatible, and closed-loop cartridges that are cell-type specific in under 30 minutes. The technology is scalable from single patient use to large-scale GMP manufacturing processes. We have developed several cartridges, primarily targeting mesenchymal stem cells for autologous transplantation and T-cells for CAR-T therapies. We are seeking commercial and research partnerships in the field of cell and gene manufacturing and novel clinical application development with clinical trials.

Visit Website
BioSharing is a Network of eight FDA licensed blood centers that have formed a corporation to provide seamless scale-up of donor derived source materials, such as GMP leukopaks, bone marrow and cord blood. With decades of experience recruiting and collecting donors, the network is uniquely positioned to supply both small and large scale quantities of source material.

Visit Website
Bluechiip understands that every sample is critical. Our objective is to manage each one with optimal quality in the most efficient way. Bluechiip’s advanced sample management solution (readers, enabled samples and software) is the only system providing sample temperature with ID in cryogenic environments delivering confidence in every sample.

Visit Website
Cellcolabs is a biotech impact start-up specializing in industrial GMP production of high-quality Mesenchymal Stromal Cells (MSC), in order to make them available at scale.

We have seen first-hand how patients who could have been significantly helped by MSC, could not receive treatment due to unavailability and unaffordability. Therefore, founded in the Swedish capital Stockholm in 2021, we have industrialized the know-how at Karolinska Institute to make high-quality GMP produced MSCs available at scale to an affordable price. Our mission is by accelerating stem cell research, making the treatments of the future available for all.

Cellcolabs builds on the findings and clinical experience from more than 20 years of stem cell research at Karolinska Institute. World renowned stem cell professor Katarina Le Blanc with research group has published 167 scientific papers with 30 000 citations (as of 2021), resulting in exceptional MSC quality. The MSC are derived from bone marrow and have been approved by Swedish Medical Product Agency (MPA) for use in two academic clinical trials in Sweden, with more clinical trials planned internationally.

Cellcolabs provides both research and GMP grade MSCs to a variety of clients, including biopharma companies, hospitals, clinics, as well as companies using MSC for other purposes.

Visit Website
Cellex Cell Professionals – your CDMO in Europe
Cellex supports biopharma and academia with a full portfolio of services around cell and gene therapy for research, clinical and commercial use worldwide.

Our company has experience in development of cGMP processes, GMP manufacturing of autologous and allogeneic cell therapy products using vectors and LNPs, quality control testing and release.

In our state-of-the-art GMP facility cellular subsets can be separated and frozen but also genetically modified and analyzed. All processes are adapted to the customers' needs, based on profound experience with EU and FDA regulations.

Cellex also stands for a successful tech transfer of processes from US to Europe.
Our apheresis centers have all techniques for collection of different starting materials from healthy donors. Cellex runs its own highly diverse donor pool and offers leukopak, bone marrow or whole blood products customized for R&D, clinical or commercial purposes.

IT and transport solutions complete the Cellex portfolio.

Visit Website
Sartorius CellGenix is a leading global supplier of high quality raw materials for the expanding cell and gene therapy and regenerative medicine space. We develop, manufacture and market human cytokines and growth factors along with GMP serum-free media. To allow for a seamless transition from preclinical development to the clinical stage we offer our human cytokines and growth factors in preclinical and GMP quality. Our products are used by academia and industry partners in clinical trials and commercial manufacturing throughout the world.

With 25 years of experience we are experts in the GMP manufacturing of raw materials for the cell and gene therapy space. As a former ATMP developer and manufacturer we gained in-depth cell culture knowledge and superior regulatory expertise. With this unique background we understand the high requirements our customers face during product development and the regulatory approval process. By offering expert technical and regulatory support we can help simplify raw material qualification and validation efforts.

Sartorius CellGenix operates a state-of-the-art GMP facility for production of recombinant proteins and cell processing in Freiburg, Germany. A subsidiary is located near Boston in Portsmouth, NH/USA.
Safe │ GMP Compliant │Reliable

Visit Website

Cellular Highways, a TTP company, is developing a new generation of automated high-throughput, scalable cell sorting instruments for research, diagnostic and therapeutic applications.

Powered by VACS, a new microfluidic cell sorter technology, our instruments will reduce the cost and complexity of cell sorting and achieve far higher throughput than existing platforms, thus making cell sorting accessible to every laboratory as well as enabling new clinical applications.

Our first product, Highway1 is designed for sterile, GMP compatible therapeutic cell sorting. Highway1 is now a beta prototype, and we are looking for testers with challenging needs. Please get in touch if you would like to be a beta tester!

Visit Website
Center for Breakthrough Medicines (CBM) is an Advanced Therapy CDMO dedicated to addressing the challenges with bringing breakthrough therapies to patients. CBM offers pre-clinical through commercial manufacturing capabilities spanning process development; plasmid DNA, viral vector, and cell therapy production; and a full suite of testing and analytical capabilities. Through a single-source, end-to-end solution, CBM accelerates time to market without compromising quality.

Visit Website
At Charles River our focus is always on anticipating tomorrow’s drug development needs today and this is why we have invested in the tools, talent and capacity to further the new frontier of cell and gene therapy development. We can support your cell and gene therapy programs every step of the way, from early discovery, manufacturing of viral vectors, plasmid and autologous/allogenic cells, toxicity/toxicology studies, to analytical release testing of your cell line characterization, biosafety and potency testing. Our global footprint, team of experienced professionals and unsurpassed portfolio of integrated services are dedicated to supporting you to help get your product to patients faster. To learn how we can help accelerate your cell and gene therapy goals, visit

Visit Website
Exclusively dedicated to Life Science and Biodiversity, Cryo Bio System strives to provide scientists and physicians with the groups’ expertise in the field of cryopreservation of biological samples, with innovative and High Security products. With 30 years of experience, Cryo Bio System is today recognized internationally for the quality of its products. Our complete range of products intended for human application allows the freezing at very low temperature of any biological sample whatever its physical state. Our unique high-security concept for long-term cryopreservation guarantees unsurpassed security and storage quality.

Visit Website
Cryoport Systems is a market leader in globally integrated temperature-controlled supply chain support for critical, irreplaceable products and materials in the life sciences industry. We are already trusted to support over 600 active clinical trials and leading commercial products worldwide - delivering unparalleled, integrated supply chain services for products, therapies and treatments requiring unique, specialized temperature-controlled management. And, as the life sciences constantly evolve and advance, so do we.

Visit Website
Digi-Trax® is the recognized leader in providing ISBT bar code compliance labeling software, hardware and supplies to healthcare. Our HemaTrax®-CT (cellular therapy) and HemaTrax® blood labeling systems are successfully operating in thousands of facilities worldwide. Our product line includes labels, printers, both mobile and desktop, scanners, ribbons and even temperature indicators and mounting accessories. With more than 30 years of experience, we have developed the optimal identification solutions for all blood and cellular therapy labeling applications. Our labels are designed for the rigorous environment in which you work. Rest assured, our cellular therapy labels will perform just as required on your cellular therapy products. We follow all FACT and ICCBBA guidelines within our HemaTrax-CT software so you can feel confident that your facility is ISBT 128 compliant. We also offer a yearly software maintenance program so that all updates and changes to these guidelines will be available for you to download. We proudly enhance our product and service offerings with complete technical service and support. Our manufacturer certified technicians can troubleshoot over the phone and resolve any situation you may encounter.

Rely on Digi-Trax for your cellular therapy and blood bank identification needs. Contact us for more information today at (800) 356-6126 or

Visit Website
coming soon

Visit Website
Excellos is a unique full-service CDMO that pairs the collection of critical human cells and tissues with manufacturing and development services to drive innovation in the cell and gene therapy industry. Built on the foundation of the San Diego Blood Bank, with over 70 years of experience in blood and tissue collection and handling, Excellos is focused on supplying cGMP cellular products and services, together with process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies.

Visit Website
Harro Höfliger specializes in the development of customer-oriented process and production solutions for pharmaceutical and medical applications as well as market-oriented consumer products. In addition to innovative machine platforms and packaging machines, customized turnkey system solutions for product assembly, processing of web materials, as well as dosing and inhalation technology are the company’s core expertise.
The systematically structured portfolio of upscalable test machines and modules, as well as requirement-oriented technology platforms, results from many years of experience and targeted research and development. Thus, Harro Höfliger covers all phases from the laboratory stage to high-performance production.

Visit Website
At Lonza Cell & Gene Technologies, we provide contract development and manufacturing services that enable pharma and biotech companies to realize life-changing cell & gene therapies for their patients. From the building blocks of life to the delivery of your therapy to patients, our solutions are created to simplify your outsourcing experience and provide a reliable outcome when you expect it. Our unmatched expertise in process development, paired with our standardized, systematic approach to cGMP manufacturing have already demonstrated our ability and capabilities to successfully take cell & gene therapies to commercialization time and time again. We continuously invest to solve not just the current, but also the future challenges. Together, let’s realize your life-changing therapy.

Visit Website
Minaris Regenerative Medicine is a global contract development and manufacturing organization (CDMO) for cell and gene therapies. We offer our clients high value clinical and commercial manufacturing services, development solutions, and technologies. We are pioneers in the field with more than 20 years’ experience providing outstanding quality and reliability. Our facilities in North America, Europe, and Asia allow us to supply patients worldwide with life-changing therapies.

Visit Website
MVE Biological Solutions
MVE Biological Solutions is the leading global manufacturer of vacuum insulated products and cryogenic systems. Over 50 years, we set the standard for storage of biological materials at low temperatures. MVE is the preferred brand for cryogenic equipment in a variety of application areas including bio-pharma cell and gene therapies, storage of cord blood and stem cells, medical research facilities, government institutions, IVF centers, hospitals and clinics, and animal husbandry and livestock.

Visit Website
Myriade develops the VIDEODROP, an innovative nanoscale imaging technology.

Based on the principles of interferometry, the Videodrop makes it possible to measure the size and concentration of biological nanoparticles like lentivirus, adenovirus or retrovirus
• in real time (40s)
• in a single drop (5µL)
• between 80nm & 500 nm
• in a concentration range of 10E8 to 10E10 part/ml
• without labelling & no purification
• on viscous & complex samples

Videodrop measures the physical titer of viral vector solutions, so it allows to:
• Continuously monitor bioproduction processes thanks to its rapidity of measurement (40s)
• Work on real samples at any stage of the bioproduction in a non-denaturant way
• Control the yield of vector production after harvesting, Purification, or Concentration steps
• Quickly identify lot-to-lot variations

Providing linear results compared to p24 ELISA, VIDEODROP is suitable for "at-line" characterization of lentiviral vectors and in-process controls.

Visit Website
NHS Blood & Transplant is dedicated to saving and improving lives. Our Cellular, Apheresis and Gene Therapy division does this by supporting the development and delivery of innovative and advanced medicines. Principal within the division is the Cellular and Molecular Therapies (CMT) function offering experience and expertise in the manufacture of cell and gene therapies through our national network of GMP-grade and MHRA-licensed facilities. From January 2023, the Clinical Biotechnology Centre (CBC), part of CMT, will be fully operational from a new purpose-built facility. This will provide increased capacity for GMP plasmid, viral vector (AAV and lentiviral) and recombinant protein manufacturing. CBC was awarded a £4.9m grant by MRC/LifeArc to create one of three Gene Therapy Innovation Hubs to accelerate academic-led development of novel gene therapies throughout the UK. Operating on a ‘not for profit’ basis, NHSBT partners with academic, commercial and NHS organisations engaged in novel cell and gene therapy programmes, supporting concepts through to clinical trials. We welcome expressions of interest for contract projects, partnerships and joint grant proposals with organisations striving to develop the future of medicine in the advanced therapies space.

Visit Website
OrganaBio is a robust and reliable biotech solutions provider for cell therapy and immunotherapy developers. OrganaBio has opened doors to a new CTDMO paradigm with a passionate commitment to ethically accelerate the deployment of cell therapies through making accessible critical resources that are essential for therapeutics development. The company’s products and services span the full development lifecycle – from proprietary blood and tissue supply chains and cellular starting materials (e.g. MSCs, HSCs, NK cells, T cells, etc.) to expert development, testing, and other support services that expedite the path to clinical translation within our state-of-the-art, ready-to-use cGMP manufacturing facility, enabling the rapid and economical manufacture of clinical materials.

Visit Website
OriGen Biomedical supplies a complete line of single use disposable products for use in Regenerative Medicine applications including T-Cell therapies. Our products are FDA-cleared, MDSAP-certified, CE-marked, cGMP-manufactured, and ISO 13485:2016 certified.

The PermaLife Cell Culture Bag is an optimal way to protect critical cell cultures. PermaLife has a user-inspired design including a needle-free, luer-actuated adapter which is self-sealing to make it easy to sample, feed, and harvest sensitive cells. The PermaLife is also gas permeable and water impermeable which eliminates the need for a humidified incubator.

The CryoStore™ Freezing Bag is the industry-preferred cryogenic freezing bag. The CryoStore™ Bag is available in a variety of configurations including a number of tubing and multi-bag options, allowing you to select the product that best fits your process.

The CryoStore™ Multi-Chamber Freezing Bag allows for cryopreservation of small volume blood components for future regenerative medicine applications. Multiple chambers are filled simultaneously through the channel at the bottom of the bag. The individual 4-6mL chambers allows for multiple post thaw applications.

CryoPur™ DMSO Solutions are certified to USP and Ph. Eur. Standards. CryoPur, CryoPur-D, CryoPur-S, and CryoPur-T Solutions come sterile, aseptic filtered and are non-pyrogenic. CryoPur™ Solutions are available as 100% DMSO and a DMSO Dextran mixture. OriGen supplies CryoPur™ in vials and syringes to meet your organization’s needs.

OriGen is known for its customer-driven product development process where OriGen can adapt its products to better fit laboratories’ protocols, not force labs to change protocols to match OriGen’s products. Visit for more information.

Visit Website
Coming Soon

Visit Website
REPROCELL's corporate vision is to promote human health by providing cutting-edge research products, services, and partnerships that advance the future of Regenerative Medicine. At REPROCELL, we manufacture custom GMP iPSC – Master Cell Banks (MCB) compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. The Seed Clones for MCB generation are made with our 4th Generation mRNA reprogramming technology. We have a bank of Seed Clones available for the Sponsor to evaluate before MCB generation, or we can prepare a Seed Clone bank specifically to meet the Sponsor's specifications. For drug discovery, REPROCELL’s pre-clinical contract research organization is an experienced partner uniquely positioned to provide custom assay services using live human tissues or 3D tissue models. Our Central Laboratory Services offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, we deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research. REPROCELL has expanded through a series of acquisitions over recent years creating a workflow including human tissue acquisition (BioServe®), RNA reprogramming (Stemgent®), 3D technologies (Alvetex®), and drug discovery (Biopta®) to the development of clinical stem cells. We can help with all areas of regenerative medicine preclinical development.

Visit Website
Since its establishment in 2000, Shanghai Model Organisms Center Inc. (SMOC) has built a rigorous and professional technical team with mature technology and complete processes. We have built more than 10,000 genetically engineered animal models, which can provide model customization services such as gene knockout, knockin, and transgenic overexpression. SMOC currently provides more than 6000 research-ready models, we have developed about 12000 genetically modified mouse strains and every year our R&D program has the capacity to create and produce more than 4000 strains. Our models are widely used in metabolic and cardiovascular disease, neurodegeneration, immunology, and oncology studies. We also provide all kinds of downstream services, such as drug screening and efficacy evaluation, etc. Our vision is to provide global researchers with professional, comprehensive and integrated animal model services.

Visit Website
SINFONIA TECHNOLOGY is a manufacturer of CellQualia* Intelligent Cell Processing (ICP) System for automatization of cell manufacturing based on our technological strength for of aerospace parts, electronic equipment, factory automation system, and motion control equipment. Basic concept of the system is to realize QbD-based cell manufacturing with a variety of process analytical technologies and Cell and Gene Therapy (CGT) 4.0 with a data management platform. We will also have a capability for contract cell manufacturing at our laboratory in Kobe. In that sense, we are not only an instrument manufacturing company, but also solution provider for stakeholders in a field of CGT.

*CellQualia is the brand name for Sinfonia Technology’s products for regenerative medicine.

Visit Website
STEMSOFT offers a full electronic solution designed to document all phases of patient care and product manufacturing to help save you time; comply with quality and accreditation requirements; and easily access a complete dataset for analysis.

Visit Website
Synthego is a leading provider of genome engineering solutions. Our flagship product, CRISPRevolution, is a portfolio of synthetic guide RNA designed for CRISPR genome editing and research. Synthego’s vision is to bring precision and automation to genome engineering, enabling rapid and cost-effective research with consistent results for every scientist.

Visit Website
Takara Bio Europe is a wholly owned subsidiary of Takara Bio Inc., who develops, manufactures, and distributes a wide range of life science reagents.

Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes)[CC1] , Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.

Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit

Visit Website
Over 45 years of experience have made Technoflex an innovative firm, as well as a European leader in the design and manufacture of flexible bags and connectors for the pharmaceutical industry.
Our cutting-edge technology and internal R&D resources enable us to provide customized, reliable and easy-to-use solutions. Our proficiency in the pharmaceutical primary packaging of injectable drugs and cell culture, allows us to produce innovative containers matching strong acceptance quality limit (AQL) level within our ISO 7 (Class 10000) clean room. Technoflex has also developed a high capacity working with all kinds of flexible films, which may be subject to high thermal amplitudes and permeability.

As for cellular therapy, SafeCell® and Cryocell® are state-of-the-art bags delivering high value in the areas of: ex-vivo cell culture, development of cell therapy treatment, blood derivatives, cryopreservation of cord blood and stem cells, and organ preservation. SafeCell®, our range of FEP bags, developed with a specific leak-proof design, offers optimal traceability. Recently Technoflex has released a new primary packaging, Dual-Mix®, for the reconstitution of unstable molecules.

Technoflex’s flexible containers are compliant with the US & EU pharmacopoeias (EP 3.1.3 & EP 3.1.6, 21CFR 77.18.10, USP class V, FDA DMF #19057, DMF #032647 and Canada DMF #2007-070).

Visit Website
TFBS Bioscience Inc. was founded in 2016 as the first Taiwanese viral vector CDMO company. However, our executive team's roots run deeper, going back to the viral-associated research laboratory in the Development Center of Biotechnology (DCB), a leading life sciences research institute in Taiwan. Through our years of service, we have accumulated good reputation in many projects with the trust of the government and the industry.

Nowadays, with our expertise in viral vector manufacturing and advanced equipment in our state-of-the-art facility, we are pioneering entrepreneurship in order to achieve our mission.

Visit Website
Title21 Health Solutions delivers easy-to-use, flexible and integrated technology to support health sciences organizations achieve compliance, gain efficiencies and ensure high quality, ultimately, to support improvement in patient safety and care.

Visit Website
coming soon

Visit Website
ViruSure is an Austrian company specialising in the virus and prion safety testing of biopharmaceutical products, such as ATMPs. Our in vitro and in vivo facilities are certified to GLP/GMP standards to ensure a high standard for all our testing. Reflecting the quality of our biosafety testing services, our reports have been submitted and accepted by regulatory authorities worldwide. We work together closely with all our customers to develop the best testing strategy for their product. Our service portfolio includes: - Cell and Virus Banking - Cell and Virus Characterization - PCR (for detection of over 130 viruses and other pathogens) - Rapid Mycoplasma Testing by qPCR - Tumorigenicity & Oncogenicity Studies - Biodistribution Studies for ATMPs - Genetic stability - NGS (R&D) - Sanger Sequencing - Virus/prion clearance studies - GMP storage - TEM

Visit Website
West is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of lifesaving and life-enhancing medicines for patients. We are guided by our core values of Passion for Customers, Leadership in Quality and One West team and these values underpin our purpose to improve patient’s lives. With nearly a century of experience, we work together with our customers to support patient health and fuel a brighter future with product innovation. West works by the side of customers from concept to patient to develop products that promote the efficiency, reliability and safety of the world’s pharmaceutical drug supply.

Visit Website
X-Therma is headquartered in Richmond, part of the San Francisco Bay Area, with research centers in Richmond and Berkeley, and now has expanded to Austria in Europe. X-Therma pioneers ground-breaking cold chain technology via a convergent biopreservation platform, to advance Regenerative Medicine and make available safe and on-demand organs, engineered tissues, cell & gene therapies, vaccines, and beyond to patients in need. X-Therma’s technology could be a paradigm shift that makes worldwide organ sharing possible and eliminates organ waiting lists across the globe. X-Therma has been a selected Industrial User at the Lawrence Berkeley National Laboratory and received over $11M contracts and grant support from the U.S. Department of Defense, the National Science Foundation, and the California Institute for Regenerative Medicine. The company recently closed an oversubscribed Series A of $13M. The FDA has granted its proprietary organ preservation solution, XT-ViVo®, and TimeSeal® Organ Transport Device, Breakthrough Device status. This designation is granted to products that have the potential to offer more effective diagnosis or treatment of life-threatening diseases with an unmet medical need.

Visit Website
One of the largest CDMO in Europe, Yposkesi offers a full range of services in LV vectors and AAV cGMP manufacturing. Within its 50,000 ft2 (soon to be 100,000 ft2) facility, Yposkesi operates 4 manufacturing suites for bulk DS (up to 1,000 L) and fill & finish.

Visit Website
Accellix 96
Aentitis Technologies  49
Akron Bio 46
Arvato Supply Chain Solutions 83
Aseptic Technologies  51
Azenta Life Sciences 17
Barkey 16
BioCentriq 50
BioLamina 44
BioLegend 100
BioLife Solutions 48
BioMérieux 43
Bionique Testing Laboratories 39
Bio-ReCell 40
BioSharing Network 101
Bluechiip 104
Cellcolabs 87
Cellex 55
Cellular Highways 20
Center for Breakthrough Medicines 82
Charles River 11
Cryo Bio System 81
Cryoport Systems 21
Cytiva  2
Digi-Trax 106
Eppendorf 79
Excellos 86
FUJIFILM Irvine Scientific 53
Harro Höfliger 97
Lonza 18
MaxCyte 3
Miltenyi Biotec 47
Minaris Regenerative Medicine 70
MVE Biological Solutions 32
Myriade 67
NHS Blood & Transplant NP90
OrganaBio 108
OriGen Biomedical 107
Rees Scientific 71
Roche CustomBiotech 95
Sartorius CellGenix 34
ScaleReady 84
Shanghai Model Organisms Center 65
Sinfonia Technology 27
STEMCELL Technologies 22
STEMSOFT Software 24
Synthego 99
Takara Bio Europe 80
Terumo Blood and Cell Technologies 1
TFBS Bioscience 31
Thermo Fisher Scientific 42
Title21 Health Solutions 36
ViruSure 39
West Pharmaceutical Services 37
WuXi Advanced Therapies 45
X-Therma 77
Yposkesi 64